QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation. 期刊论文 Annals of hematology, 2019 作者:  Haiwen Huang;  Lihong Zhang;  Yibin Jiang;  Shuo Liu;  Zhengming Jin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/13 Autologous  stem  cell  transplantation  High-dose  chemotherapy  Lymphoma  Modified  BuCy  SEAM   Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases study. 期刊论文 Frontiers of medicine, 2019 作者:  Wang Ling;  Wang Ying;  Hu Jiong;  Sun Yuqian;  Huang He 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13 chemotherapy  hematological  malignancies  invasive  fungal  diseases  prophylaxis  risk  score   Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety 期刊论文 2019, 卷号: 13, 期号: 3, 页码: 344-353 作者:  Huang, Xiaojun;  Jiang, Qian;  Hu, Jianda;  Li, Jianyong;  Jin, Jie 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 chronic myeloid leukemia (CML)  dasatinib  tyrosine kinase inhibitor  long-term follow-up   Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation 期刊论文 2019, 卷号: 25, 期号: 8, 页码: 1674-1681 作者:  Xuan Li;  Wang Yu;  Chen Jia;  Jiang Erlie;  Gao Li 收藏  |  浏览/下载：17/0  |  提交时间：2020/01/03 Acute myeloid leukemia  Allogeneic hematopoietic stem cell transplantation  FMS-like tyrosine kinase 3 internal tandem duplication  Relapse  Sorafenib   Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial 期刊论文 2019, 卷号: 25, 期号: 3, 页码: E153-E158 作者:  Yang, Renchi;  Sun, Jing;  Zhao, Yongqiang;  Wang, Xuefeng;  Wu, Depei 收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03 BAY 81-8973  Chinese  clinical trial  factor VIII  haemophilia  prophylaxis   Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT 期刊论文 2019 作者:  Xuan Li;  Wang Yu;  Chen Jia;  Jiang Erlie;  Gao Li 收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03 FMS-like tyrosine kinase 3 internal tandem duplication  acute myeloid leukemia  allogeneic hematopoietic stem cell transplantation  relapse  sorafenib